Overview
Cocaine-induced mood disorders encompass a spectrum of neuropsychiatric symptoms including mood disturbances, often secondary to cerebrovascular complications or direct neurotoxic effects of cocaine use. These conditions can manifest acutely and may require nuanced management beyond cessation of drug use.Diagnosis
Clinical Presentation: Neurological deficits, mood changes, and psychiatric symptoms often occur within hours of cocaine use. 23
Imaging Studies: MRI and CT angiography (CTA) are crucial for identifying cerebrovascular events such as infarcts, hemorrhages, and vasospasm. 23
Laboratory Tests: ANCA serology may be considered, particularly in cases with midline destructive lesions, though its predictive value for disease severity remains unclear. 1
Perfusion Imaging: CT perfusion (CTP) aids in differentiating multifocal vasospasm-related ischemia from thromboembolic stroke. 2Management
Immediate Stabilization: Focus on supportive care, including neurological monitoring and management of acute symptoms. 23
Avoid Thrombolytics: Exclude thrombolytic therapy in suspected vasospasm to prevent exacerbating ischemia. 2
Cessation Support: Provide counseling and pharmacotherapy (e.g., buprenorphine, naltrexone) to aid in cocaine cessation. 3
Psychiatric Intervention: Consider psychiatric evaluation and treatment for mood disorders, possibly including antidepressants or mood stabilizers. 3Special Populations
Comorbidities: Patients with other stroke risk factors may require tailored management strategies, though specific guidelines are limited. 3
No Specific Data on Pregnancy, Pediatrics, or Elderly: The abstracts do not provide detailed insights into these populations. 123Key Recommendations
Utilize imaging modalities such as MRI, CTA, and CTP to accurately diagnose cerebrovascular complications in cocaine users. (Evidence: Moderate) 23
Avoid thrombolytic therapy in suspected cases of cocaine-induced multifocal vasospasm to prevent worsening ischemia. (Evidence: Weak) 2
Integrate psychiatric support alongside neurological care to address mood disorders arising from cocaine use. (Evidence: Expert opinion) 3References
1 Pendolino AL, Benshetrit G, Navaratnam AV, To C, Bandino F, Scarpa B et al.. The role of ANCA in the management of cocaine-induced midline destructive lesions or ENT pseudo-granulomatosis with polyangiitis: a London multicentre case series. The Laryngoscope 2024. link
2 Mehta SV, Gluncic V, Iqbal SM, Frank J, Ansari SA. Role of perfusion imaging in differentiating multifocal vasospasm-related ischemia versus thromboembolic stroke in a setting of cocaine abuse. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2012. link
3 Daras M, Tuchman AJ, Koppel BS, Samkoff LM, Weitzner I, Marc J. Neurovascular complications of cocaine. Acta neurologica Scandinavica 1994. link